Thank you Drakemaster!
I had not thought of the possible problem of sustainability of sheep intestines. Good point!
I agree that most of the answers from investor relations have not added much. The one very encouraging point was that Osteopore does not pay the researchers. That puts it already at a great advantage over most ASX biotech companies. I am hoping that it does not pay for the studies either, or at least that the academic institutions contribute a great deal. I will try for a response to that question..
- Forums
- ASX - By Stock
- Ann: Notification regarding unquoted securities - OSX
Thank you Drakemaster!I had not thought of the possible problem...
Featured News
Add OSX (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.9¢ |
Change
-0.001(1.67%) |
Mkt cap ! $6.759M |
Open | High | Low | Value | Volume |
6.0¢ | 6.0¢ | 5.9¢ | $16.25K | 275.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 75000 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 335779 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.058 |
2 | 93019 | 0.057 |
4 | 461006 | 0.056 |
5 | 228181 | 0.055 |
1 | 200000 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.063 | 100000 | 1 |
0.064 | 16666 | 1 |
0.065 | 207250 | 3 |
0.066 | 139181 | 2 |
0.067 | 33333 | 1 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
OSX (ASX) Chart |